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http://www.biolres.com/content/47/1/8RESEARCH ARTICLE Open AccessRole of berberine in ameliorating Schistosoma
mansoni-induced hepatic injury in mice
Mohamed A Dkhil1,2Abstract
Background: Schistosomiasis is caused by helminth parasites of the genus Schistosoma. Berberine chloride (BER),
an isoquinoline alkaloid, has been used in vivo for its antiparasitic, antioxidant and hepatoprotective properties.
In this study, the protective effect of BER and praziquantel has been compared for the extent of schistosomiasis-
induced oxidative stress in hepatic tissue of mice.
Results: S. mansoni was able to induce inflammation and injury to the liver, evidenced (i) by an increase in
inflammatory cellular infiltrations, dilated sinusoids and vacuolated hepatocytes, (ii) by decreased levels of alanine
and aspartate aminotransferases and increased levels of alkaline phosphatase, γ-glutamyl transferase in the liver
homogenate, (iii) by increased production of nitric oxide and thiobarbituric acid reactive substances, and (iv) by
lowered glutathione levels and decreased activities of catalase and superoxide dismutase, respectively. All these
infection-induced parameters were significantly altered during BER treatment. In particular, berberine counteracted
the S. mansoni-induced loss of glutathione and the activities of catalase and superoxide dismutase.
Conclusion: Based on these results, it is concluded that berberine could ameliorate pre-existing liver damage and
oxidative stress conditions due to schistosomiasis.
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Schistosomiasis is a chronic, parasitic disease caused by
blood flukes (trematode worms) of the genus Schisto-
soma. More than 207 million people are infected world-
wide, with an estimated 700 million people at risk in
74 endemic countries (WHO, [1]). Experimental infec-
tion of laboratory animals with Schistosoma mansoni
has been frequently used as a model for the analysis
of the pathological and physiopathological aspects of
human infection [2].
There is as yet no vaccine available for Schistosomiasis
and the current mainstay of control is chemotherapy
with praziquantel (PZQ). In view of concern about the
development of tolerance and/or resistance to PZQ,
there is a need for research into and development of
novel drugs for the prevention and cure of schistosomia-
sis [3]. Moreover, PZQ is associated with considerableCorrespondence: mohameddkhil@yahoo.com
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stated.adverse clinical effects, some occurring within 24 hours
[3]. Although the precise mechanism of action of PZQ
has not been clarified, it appears to cause severe spasms
and paralysis of the worms’ muscles. This paralysis is ac-
companied–and probably caused–by a rapid influx of Ca 2+
inside the schistosome [4,5].
Although chemotherapy is still one of the most ef-
fective methods for controlling schistosomiasis [6], the
value of many of the plant species that have been used
throughout the world in traditional medicine for the
treatment of both veterinary and human helminthes is
increasingly being recognised [7]. Few plants, however,
have been screened for activity against adult Schistosoma
sp., although some medically important species, such as
Zingiber officinale, Nigella sativa and Asparagus officina-
lis, do show an effect against schistosomiasis [8,9].
Berberine is an isoquinoline alkaloid with a long his-
tory of medicinal usage. It is a well-known naturally oc-
curring medicine derived from the root and the stem
bark of numerous clinically important medicinal plants
such as Hydrastis canadensis (goldenseal), Berberis aqui-
folium (Oregone grape), Berberis aristata (tree turmeric),is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Berberine extracts and decoctions have demonstrated sig-
nificant antimicrobial and antiparasitic activity against a
variety of organisms including bacteria, viruses, fungi,
protozoans, helminths and Chlamydia [11]. Extensive re-
search within the past decade indicates that berberine is
associated with a wide range of pharmacological effects,
including antioxidative [12], anti-inflammatory [13], and
immunoregulative [14] activities. Several studies have also
demonstrated the inhibitory effects of berberine on chem-
ically induced cytotoxicity, lipid peroxidation and oxida-
tive stress in the liver [15,16]. In this context, the current
study aimed to investigate the role of berberine against
schistosomiasis-induced hepatic damage in mice.
Results
Histological investigation of hepatic tissue sections re-
vealed that S. mansoni caused a severe granulomatous
inflammatory response in the liver, as indicated by inflam-
matory cellular infiltration as well as cytoplasmic vacuol-
ation and degeneration of hepatocytes. Granulomas were
marked by concentric fibrosis with many fibroblasts en-
circling the trapped eggs. They were surrounded by a cuff
of aggregated lymphocytes, epitheloid cells, eosinophils
and collagenous fibres. The presence of numerousFigure 1 Histological changes in hepatic tissue of non-infected and in
with normal architecture. (B) Non-infected, PQZ treated mouse liver with n
normal structure. (D,E) Infected liver from group 4 with prominent inflamm
sinusoidal dilatations (white arrow) and hepatocytic vacuolation. (F,G) Infec
(H,I) Infected berberine treated mouse liver from group 6 showing reduced
Bar = 50 μm.granulomas resulted in disorganization of the hepatic
strands and lobular structure. In addition, the hepatic
sinusoids were dilated and apparently contained more
Kupffer cells (Figure 1).
Berberine administration induced a significant reduction
in the size of this granulomatous inflammation compared
to the livers of infected untreated animals (Figure 1 and
Figure 2). While the diameter of the granulomas reached
approximately 300 ± 15.8 μm in infected livers, treatment
with berberine significantly reduced their diameter to
190 ± 16.3 μm. This reduction in granuloma size was simi-
lar to that in the PZQ treated group (Group 5) (Figure 1
and Figure 2). In the berberine treated group, meanwhile
(group VI), the hepatic lobular architecture appeared to
be restored its normal organization and most hepatocytes
showed a normal appearance, even in the vicinity of the
granulomas. Some sinusoids remained dilated and infil-
trated with lymphocytes, however, and some Kupffer cells
were still hypertrophied (Figure 1). All these alterations
are considered through the histological liver activity index
compiled according to Ishak et al. [17], which were cate-
gorized from 9-16 for the infected livers in comparison to
1-3 for non-infected controls (Table 1). Moreover, mice
treated with PQZ and berberine displayed a highly signifi-
cant increase in the percentage of egg reduction in thefected mice with S. mansoni on day 55 p.i. (A) Non-infected liver
ormal structure. (C) Non-infected, berberine treated mouse liver with
ation (black arrow heads) especially around granuloma (black arrow),
ted PQZ treated mouse liver from group 5 showing fewer lesions.
tissue damage. Sections are stained with hematoxylin and eosin.
Figure 2 Reduction in granuloma size in the livers of mice
infected with S. mansoni and treated with berberine. Values are
means ± SD (n = 8). *Significant change at P ≤ 0.05.
Figure 3 Egg density in the hepatic tissues of mice infected
with S. mansoni and treated with PQZ or berberine. Values are
means ± SD (n = 8). *Significant change at P ≤ 0.05.
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tively (Figure 3).
Most previous studies have determined the activities
of the liver enzymes in the blood serum. In this study,
the activities of ALT, AST, ALP and γ-GT have been
measured in the liver homogenates. The activities of
ALT and AST in our study were significantly decreased
in the liver homogenate of the infected mice (group 3)
by approximately 40% and 50%, (P < 0.05), respectively
(Table 2). Liver ALP and γGT in group 3, meanwhile,
were significantly elevated by 55% and 48%, (P < 0.05),
respectively. Again, both PQZ and berberine treatments
were associated with significant changes in these liver
parameters, as can be seen from Table 2.
S. mansoni also induced a highly significant increase in
hepatic NO (Figure 4) and MDA (Figure 5) by approxi-
mately 3.5 and 2.3 fold, respectively. Treatment with
berberine, however, significantly reduced the S. mansoni-
induced increase in TBARS and NO (Figure 4 and
Figure 5). Finally, some major components involved in the







Control 1 0 0
PZQ 3 0 0
BER 2 + 0
Infected 14-16 +++ +++
Infected + PZQ 9-11 ++ +
Infected + BER 9-12 + +
aModified according to Ishak et al. [17]. Score: 1–3, minimal; 4–8, mild; 9–12, moderstress, such as GSH, catalase and SOD, have been deter-
mined (Table 3). It was striking that these substances were
significantly down-regulated by S. mansoni infection but
that these effects were largely prevented by berberine
treatment (Table 3).
Discussion
The pharmacologic actions of berberine include metabolic
inhibition of certain organisms, inhibition of enterotoxin
formation, inhibition of intestinal fluid accumulation and
ion secretion, inhibition of smooth muscle contraction, re-
duction of inflammation and inhibition of platelet ag-
gregation [11]. Praziquantel, meanwhile, works by causing
severe spasms and paralysis of the worms’ muscles. This
paralysis is accompanied–and probably caused–by a rapid
influx of Ca 2+ inside the schistosome (Doenhoff et al.,
2008). Berberine is not considered toxic at doses used in
clinical situations, nor has it been shown to be cytotoxic
or mutagenic [11].
In this study, the administration of berberine for
10 days was shown to have a pronounced antischistoso-










0 0 0 0
+ + 0 0
0 + 0 0
++ +++ +++ ++
+ ++ ++ +
+ ++ + +
ate; 13–18, severe. 0: absent; +: mild; ++; moderate; and +++: severe.
Table 2 Effect of berberine chloride on hepatic ALT, AST,
ALP and γGT in male mice infected with S. mansoni
Experimental
groups
ALT AST ALP γ-GT
(U/g) (U/g) (U/g) (U/g)
Control 304 ± 1.8 229 ± 1.8 16 ± 1 25 ± 0.8
PZQ 315 ± 1.7a 220 ± 4.5a 13 ± 0.3a 18 ± 1a
BER 318 ± 1.4a 255 ± 2.3a 7.4 ± 0.4a 15 ± 0.8a
Infected 218 ± 3.6a 125 ± 1a 36 ± 1.2a 48 ± 1.6a
Infected + PZQ 263 ± 1.3abc 146 ± 1.9 abc 17 ± 1bc 16 ± 0.5ac
Infected + BER 280 ± 2.8abc 182 ± 2.4abc 12 ± 1.6abc 20 ± 0.6abc
Values are means ± SD (n = 8). aSignificant difference as compared with Group I
(p ≤ 0.05). bSignificant difference as compared with corresponding control
group (p ≤ 0.05). cSignificant difference as compared with infected group
(Group IV) (p ≤ 0.05).
Figure 5 Effect of berberine on the level of malondialdehyde in
liver homogenates of mice infected with S. mansoni. Values are
means ± SD (n = 8). aSignificant difference compared to Group 1
(p ≤ 0.05). bSignificant difference compared to the corresponding
control group (p≤ 0.05). cSignificant difference compared to the
infected group (Group 6) (p≤ 0.05).
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heavier infection have more total hepatic fibrosis. The
study showed the relationship between trapped eggs and
encircling fibroblasts, supporting the work of Chesney
et al., [19], who described the infiltration of circulating
fibroblasts into granulomas and speculated that these cells
may be important for attracting lymphocytes as well as
forming collagen. Our results show the action of ber-
berine in the form of a significant reduction in egg
numbers (Figure 3) together with a significant reduc-
tion in the size of granulomas, and a decrease in the
number of involutive granulomas compared with the in-
fected control mice. Taken together, these findings suggest
a possible antifibrotic role of berberine [20,21]. The com-
monly encountered hepatic alterations in untreated ani-
mals were periportal inflammation, sinusoidal infiltration
and Kupffer cell activation these features were reduced inFigure 4 Effect of berberine on the level of NO in the liver
homogenates of mice infected with S. mansoni. Values are
means ± SD (n = 8). aSignificant difference compared to Group 1
(p ≤ 0.05). bSignificant difference compared to the corresponding
control group (p≤ 0.05). cSignificant difference compared to the
infected group (Group 6) (p≤ 0.05).animals treated with berberine, further supporting the
suggestion of its fibrinolytic effect [20,21].
S. mansoni infection is known to induce hepatocellular
injury, which in turn, leads to the release of enzymes
from the injured hepatic cells into blood circulation [22].
In the present study, the significantly lower levels of
AST and ALT in the liver homogenates from the in-
fected groups may be due to the existence of the inflam-
matory hepatic granuloma reported to be present as a
result of egg deposition and the presence of worms and
their toxins. Other investigators have found increases in
serum transaminases in S. mansoni infected animals
[23]. The results obtained in this study showed that the
anitinflammatory activity of berberine was slightly re-
flected in an improvement of the status of the bilharzial
livers.Table 3 Effect of berberine on liver glutathione, catalase





(mmol/g liver) (U/g liver) (U/g liver)
Control 0.8 ± 0.02 1.3 ± 0.04 1455 ± 8.5
PZQ 1.1 ± 0.02a 1.4 ± 0.04 1371 ± 1.4a
BER 1.2 ± 0.02a 1.6 ± 0.01a 1589 ± 6.2ab
Infected 0.61 ± 0.02a 0.75 ± 0.02a 859 ± 1.3a
Infected + PZQ 0.76 ± 0.08ab 1.3 ± 0.01bc 902 ± 2.2abc
Infected + BER 0.67 ± 0.02ab 1.2 ± 0.03bc 924 ± 1.7abc
Values are means ± SD (n = 8). aSignificant difference as compared with Group I
(p ≤ 0.05). bSignificant difference as compared with corresponding control
group (p ≤ 0.05). cSignificant difference as compared with infected group
(Group IV) (p ≤ 0.05).
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radicals and the disturbance of the cellular antioxidant
system. It is known that antioxidant processes play an
important role in mediating liver injury in schistosomia-
sis due to the increased production of reactive oxygen
intermediates [24]. Hence, the suppressive effect of ber-
berine on the formulation of granulomas is probably
due, in part, to the fact that berberine has an antioxidant
effect [25].
GSH is known to play an important role in antioxidant
defence, both directly through the scavenging of reactive
oxygen species, and indirectly through its function as a
cofactor of antioxidant enzymes [26]. It has also been re-
ported that schistosomiasis causes an impairment of the
liver GSH content of mice, thus serving to decrease the
antioxidant capacity of the liver and leading to the gener-
ation of lipid peroxides that may in turn play a central role
in the pathology associated with schistosomiasis [27]. In
the present study, hepatic GSH decreased significantly (by
approximately 31.5%) in infected treated mice, compared
to the normal control group, which indicates that schisto-
somiasis causes more liberation of free radicals. Berberine
treatment, however, decreased both hepatic lipid peroxi-
dation and GSH depletion strongly suggesting that berber-
ine is an effective antioxidant in this context.
It was observed that the infection caused significant
increases in the hepatic TBARS levels. Berberine treat-
ment prevented the increase in TBARS, probably in part
by scavenging the very reactive components. Moreover,
high rate of oxidative processes, formation of hepatic
TBARS due to the peroxidative damage to the liver mi-
crosomal membrane lipid and impairment of the anti-
oxidant defense characterize schistosomiasis [28].
Catalase (CAT) has been regarded as a major deter-
minant of hepatic antioxidant status by catalyzing the re-
duction of hydrogen peroxides and protecting tissue from
highly reactive hydroxyl radicals. A decrease in CAT activ-
ity could result from inactivation by superoxide radicals
and glycation of the enzymes [29]. Moreover, CAT is
known to be involved in detoxification of high H2O2 con-
centrations, whereas glutathione peroxidase is sensitive to
lower concentrations of H2O2 [29].
Results obtained with berberine are a clear indication
of the importance of berberine for the treatment of S.
mansoni infection, which is comparable to that of
praziquantel.
Conclusion
Collectively, the findings of the present investigation
suggest that the way in which BER exerts its beneficial
effects on S. mansoni-induced oxidative stress may be at-
tributed to its antioxidant activity, and that this action
could find a clinical use in the treatment of hepatic dys-
function in schistosomiasis. Further studies are stillnecessary, however, in order to elucidate the exact
mechanism of this modulatory effect, and to examine its
potential therapeutic effects in more detail.
Methods
Animals
Swiss albino mice were bred under specified pathogen-
free conditions and fed a standard diet and water ad
libitum. The experiments were performed only with
male mice at an age of 9-11 weeks; they were approved
by state authorities and followed Egyptian rules for ani-
mal protection.
Infection of mice
S. mansoni cercariae were from the Schistosome Bio-
logical Supply Center at Theodor Bilharz Research Institute,
Imbaba, Giza, Egypt. Mice were exposed to 100 ± 10
S. mansoni cercariae per mouse by the tail immersion
method, modified by Oliver and Stirewalt [30].
Experimental design
Animals were allocated to six groups of eight mice each.
Group one served as a control group and received water
(100 μl water/mouse) by oral administration for 10
days. Group two was treated with Praziquantel (PZQ)
at 500 mg/Kg via 70% glycerine on two successive days.
Group three were gavaged with 100 μl of 12 mg/kg ber-
berine chloride (one-third of the 50% lethal dose) (Sigma,
St. Louis, MO, USA) [31] for 10 days. Groups four, five
and six were infected with 100 ± 10 S. mansoni cercariae.
On day 46 p.i. with S. mansoni, the animals of groups five
and six were given PZQ and Berberine by gavage at the
same doses as groups two and three, respectively. On day
55 p.i with S. mansoni, the animals of all groups were
killed. Part of the liver was weighed and homogenized im-
mediately to give a 50% (w/v) homogenate in an ice-cold
medium containing 50 mM Tris–HCl and 300 mM su-
crose, pH 7.4 [32]. The homogenate was centrifuged at
500 × g for 10 min at 4°C. The supernatant (10%) was used
for the various biochemical determinations.
Egg count in the liver
The eggs in the liver of infected mice were counted ac-
cording to Pellegrino et al. [33]. In brief, the number of
eggs per gram of liver tissue was determined by weigh-
ing a piece of liver (0.1 g) and divided it into four frag-
ments, each fragment being crushed between a slide and
a cover slip. The fragments were then examined by light
microscope and the number of eggs counted.
Histology of the liver
Tissue samples from the livers of mice from each of the
groups were immediately fixed after animal dissection in
10% neutral buffered formalin, dehydrated and processed
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and stained with hematoxylin and eosin. Histological
damage was scored according to Jamshidzadeh et al. [34]
as follows: 0: absent; +: mild; ++; moderate; and +++: se-
vere. The liver activity index was estimated using a modi-
fied quantitative Ishak scoring system [17]; scores of 1-3
were assigned to cases of minimal liver damage, scores of
4-8 to mild, scores of 9-12 to moderate and scores of
13-18 to severe cases. To assess the size of tissue granu-
loma, the mean diameter (μm) was measured. For each




Colorimetric determination of alanine aminotransfe-
rase (ALT) and aspartate aminotransferase (AST) was
estimated by measuring the amount of pyruvate and
oxaloacetate, respectively, produced by forming 2, 4-
dinitrophenylhydrazine. The colour of which was mea-
sured at 546 nm according to Reitman and Frankel [35].
Alkaline phosphatase
Alkaline phosphatase (ALP) was assayed in the liver ho-
mogenates using kits provided by Biodiagnostic Com-
pany (Giza, Egypt). Also, Total Bilirubin (TB) of serum
was assayed according to the method of Schmidt and
Eisenburg [36].
γ-Glutamyl transferase
γ-Glutamyl transferase (γGT) was estimated in the liver
homogenates according to the method described by Szasz
[37]. The substrate L-γ-glutamyl-4-nitroanilide, in the pre-
sence of glycylglycine, is converted by γGT in the sample
to 4-nitroaniline which was measured at 405 nm in a
Jasco-Japan-V530 spectrophotometer.
Glutathione
Glutathione (GSH) was determined chemically in the
liver homogenates using Ellman’s reagent [38]. This me-
thod is based on the reduction of Ellman’s reagent (5,5′
dithiobis (2-nitrobenzoic acid) with GSH to produce a
yellow compound. The chromogen is directly propor-
tional to the GSH concentration and its absorbance was
measured at 405 nm.
Determination of thiobarbituric acid reactive substances
Thiobarbituric acid reactive substances (TBARS) were
assayed through colorimetric tests of the liver homoge-
nates according to the method of Ohkawa et al. [39]. In
this method, TBARS was determined by using 1 ml of
trichloroacetic acid 10% and 1 ml of thiobarbituric acid
0.67% which were then heated together in a boiling waterbath for 30 min. TBARS were then determined by the ab-
sorbance at 535 nm and expressed as TBARS formed.
Nitric oxide
The assay of nitric oxide (NO) in the liver homogenates
was done according to the method of Berkels et al., [40].
In an acid medium, and in the presence of nitrite, the
formed nitrous acid diazotises sulphanilamide, and this
is then coupled with N-(1–naphthyl) ethylenediamine.
The resulting azo dye has a bright reddish–purple colour
which was measured at 540 nm.
Statistical analysis
One-way ANOVA was carried out, and the statistical
comparisons among the groups were performed with
Duncan’s test using a statistical package program (SPSS
version 17.0). All p values are two-tailed and P < 0.05
was considered as significant for all statistical analysis in
this study.
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